Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Inhibitor Therapeutics, Inc. | Director | Common Stock | 896K | Apr 1, 2024 | Direct | ||
Telomir Pharmaceuticals, Inc. | Chief Financial Officer | Incentive Stock Options (right to buy) | 200K | Aug 27, 2024 | Direct | ||
MIRA PHARMACEUTICALS, INC. | Chief Financial Officer | Incentive Stock Option (right to buy) | 57.8K | Mar 26, 2024 | Direct | ||
Telomir Pharmaceuticals, Inc. | Chief Financial Officer | Common Stock | 24.4K | Jun 18, 2024 | Direct | ||
MIRA PHARMACEUTICALS, INC. | Chief Financial Officer | Stock Options | 20K | Aug 17, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TELO | Telomir Pharmaceuticals, Inc. | Aug 27, 2024 | 1 | $0 | 4 | Sep 4, 2024 | Chief Financial Officer |
TELO | Telomir Pharmaceuticals, Inc. | Jun 18, 2024 | 0 | $0 | 3 | Aug 29, 2024 | Chief Financial Officer |
INTI | Inhibitor Therapeutics, Inc. | Apr 1, 2024 | 1 | $0 | 4 | May 16, 2024 | Director |
MIRA | MIRA PHARMACEUTICALS, INC. | Mar 26, 2024 | 1 | $0 | 4 | Mar 27, 2024 | Chief Financial Officer |
MIRA | MIRA PHARMACEUTICALS, INC. | Aug 17, 2023 | 1 | $0 | 4 | Aug 21, 2023 | CFO, Secretary and Treasurer |
MIRA | MIRA PHARMACEUTICALS, INC. | Aug 2, 2023 | 0 | $0 | 3 | Aug 2, 2023 | CFO, Secretary & Treasurer |
INTI | Inhibitor Therapeutics, Inc. | May 5, 2023 | 1 | $0 | 4 | May 17, 2023 | Director |
INTI | Inhibitor Therapeutics, Inc. | Dec 13, 2022 | 0 | $0 | 3 | Dec 22, 2022 | Director |